US Patent 10689439 Optimized anti-TL1A antibodies
Patent 10689439 was granted and assigned to Prometheus Biosciences on June, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10689439 Optimized anti-TL1A antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
